KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to -$27.1 million.

  • Neogenomics' Consolidated Net Income fell 53.28% to -$27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.5 million, marking a year-over-year decrease of 45.98%. This contributed to the annual value of -$78.7 million for FY2024, which is 10.51% up from last year.
  • As of Q3 2025, Neogenomics' Consolidated Net Income stood at -$27.1 million, which was up 39.84% from -$45.1 million recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Consolidated Net Income peaked at $75.9 million during Q2 2021, and registered a low of -$49.4 million during Q1 2022.
  • Over the past 3 years, Neogenomics' median Consolidated Net Income value was -$24.3 million (recorded in 2023), while the average stood at -$24.1 million.
  • Data for Neogenomics' Consolidated Net Income shows a peak YoY increase of 1,211.86% (in 2021) and a maximum YoY decrease of 895.78% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Neogenomics' Consolidated Net Income stood at -$41.8 million in 2021, then spiked by 45.67% to -$22.7 million in 2022, then spiked by 36.85% to -$14.3 million in 2023, then decreased by 6.97% to -$15.3 million in 2024, then crashed by 53.28% to -$27.1 million in 2025.
  • Its last three reported values are -$27.1 million in Q3 2025, -$45.1 million for Q2 2025, and -$25.9 million during Q1 2025.